Sonoma Biotherapeutics Launches 83,000-Sq-Ft Seattle Waterfront R&D Center for Autoimmune Disease Research

Sonoma Biotherapeutics opened a new 83,000-square-foot R&D center on Seattle's waterfront to consolidate its staff and advance early-stage autoimmune disease research using regulatory T cells. The facility accommodates 65 scientists and is equipped with flexible lab spaces and advanced scientific equipment.